Status:
COMPLETED
A Prospective RegistrY of Cardiac Echographic Loops
Lead Sponsor:
Cardiawave SA
Conditions:
Calcified Aortic Valve
Eligibility:
All Genders
18+ years
Brief Summary
CARDIAWAVE, a French start-up founded in 2014, aims to develop a new non-invasive therapy to treat patients suffering from Aortic Valve Stenosis (AS) who are not candidates to validated treatment of A...
Eligibility Criteria
Inclusion
- Patients aged ≥ 18 y.o
- Patients with a confirmed diagnosis of Aortic valve calcification on native valve or bioprosthesis
- Patients with planned cardiac transthoracic echography for 'Aortic valve calcification' follow-up
- Patients who have signed Informed Consent Form
- Patients affiliated to French social security or equivalent
Exclusion
- Patients allergic to echographic gel
- Patients with "hostile thorax": serious cutaneous irradiation injury or major thoracic deformity.
- Low echogenicity
- Patients with mild or high abundance pericardic effusion
Key Trial Info
Start Date :
July 19 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03371524
Start Date
July 19 2017
End Date
February 1 2019
Last Update
October 5 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Caen
Caen, France, 14000
2
Hôpital Européen Georges Pompidou
Paris, France, 75015
3
Hôpital Charles Nicolle
Rouen, France, 76000